Leonteq Securities AG’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.99K Hold
174
﹤0.01% 1092
2026
Q1
$3.25K Hold
174
﹤0.01% 1144
2025
Q4
$4.02K Hold
174
﹤0.01% 1274
2025
Q3
$4.67K Sell
174
-12,192
-99% -$291K ﹤0.01% 1176
2025
Q2
$208K Buy
12,366
+5,448
+79% +$96K 0.01% 560
2025
Q1
$122K Buy
6,918
+4,379
+172% +$87.8K 0.01% 651
2024
Q4
$61.7K Buy
2,539
+2,343
+1,195% +$66.9K ﹤0.01% 788
2024
Q3
$7.28K Sell
196
-12
-6% -$448 ﹤0.01% 1009
2024
Q2
$9.9K Sell
208
-48
-19% -$2.1K ﹤0.01% 980
2024
Q1
$9.8K Sell
256
-525
-67% -$17.1K ﹤0.01% 1013
2023
Q4
$24.4K Buy
+781
New +$28.1K ﹤0.01% 915
2023
Q2
Sell
-117
Closed -$7.48K 1310
2023
Q1
$7.48K Sell
117
-10
-8% -$653 ﹤0.01% 1072
2022
Q4
$6.17K Sell
127
-14
-10% -$878 ﹤0.01% 1114
2022
Q3
$9.95K Hold
141
﹤0.01% 1058
2022
Q2
$10K Sell
141
-12
-8% -$773 ﹤0.01% 1082
2022
Q1
$12.2K Hold
153
﹤0.01% 1082
2021
Q4
$14K Hold
153
﹤0.01% 1121
2021
Q3
$19.7K Buy
+153
New +$21.4K ﹤0.01% 994

Other funds holding STAA

Leonteq Securities AG's STAA Position: Q2 2026 in Review

Leonteq Securities AG held its STAAR Surgical (STAA) position steady in Q2 2026 at 174 shares worth $4.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Leonteq Securities AG first reported a position in STAA in Q3 2021 and has held it in 18 quarters since. The position peaked at $208K in Q2 2025. 199 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Leonteq Securities AG held 174 shares of STAAR Surgical worth $4.99K as of Q2 2026.
  • Leonteq Securities AG left its STAAR Surgical share count unchanged in Q2 2026.
  • STAAR Surgical made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1092 holding.
  • Leonteq Securities AG first reported a position in STAAR Surgical in Q3 2021 and has held it in 18 quarters since.
  • Leonteq Securities AG's STAAR Surgical position peaked at $208K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.